Stromal Cells for GVHD Prevention

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease After Allogeneic Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies and Myelodysplasia

What's the purpose of the trial?

The protocol is a phase I open label study evaluating the safety and feasibility of peri-transplant infusion of freshly expanded interferon gamma primed MSCs in adult and pediatric patients undergoing HCT for acute leukemia and myelodysplastic syndrome (MDS).
Trial status

Not currently accepting

Phase
Phase 1
Enrollment
45
Last Updated
2 months ago
Am I Eligible

Participating Centers

There are 2 centers participating in this trial. Enter a location below to find the closest center.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • IFN-γ (interferon gamma-1b) injection is a manufactured version of a protein made by white blood cells called interferon that may help the body fight infections.

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Accepting patients

Pediatric Population

Not currently accepting

Adult Population

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.